{
    "Common": {
        "LogoAlt": "[es]Rare Genome Project logo",
        "ApplyButton": "[es]Apply"
    },
    "Banner": {
        "Text": "[es]For updates on how COVID-19 is impacting our study, please click",
        "LinkText": "[es]here."
    },
    "Header": {
        "Families": {
            "Text": "Para las familias",
            "Item1": "Criterios de idoneidad",
            "Item2": "Para comenzar",
            "Item3": "Privacidad y empleo de los datos",
            "Item4": "Para el médico"
        },
        "Researchers": {
            "Text": "Para los investigadores",
            "Item1": "Acceso a los datos"
        },
        "Projects": {
            "Text": "Proyectos especializados",
            "Item1": "Distrofia muscular de cinturas",
            "Item2": "Craneofacial"
        },
        "AboutUs": "Quiénes somos",
        "FAQs": "Preguntas y respuestas",
        "Dashboard": "[es]Dashboard",
        "GetStarted": "Cómo comenzar"
    },
    "Footer": {
        "Navigation": {
            "Home": "Página principal",
            "AboutUs": "Quiénes somos",
            "Apply": "Solicitud",
            "Back": "Volver arriba"
        },
        "Address": {
            "Text": "Comuníquese con nosotros:",
            "Line1": "Broad Institute of MIT and Harvard",
            "Line2": "415 Main Street, Cambridge, MA 02142 United States"
        },
        "FacebookAlt": "[es]Facebook"
    },
    "HomePage": {
        "Title": "[es]If you or your family member has a rare and genetically undiagnosed condition, you may be eligible to join a patient-driven research study aimed at discovering the genes underlying your family’s rare disease.",
        "Text": "[es]The Rare Genomes Project (RGP) at the Broad Institute of MIT and Harvard is a patient-driven research study led by genomics experts and clinicians who believe that the latest advances in genomic sequencing are changing medicine and should be accessible to families with rare and undiagnosed conditions.",
        "IllustrationAlt": "[es]Rare people illustration",
        "DNAAlt": "[es]DNA Strand Illustration",
        "MainPoints": {
            "Discovery": {
                "Title": "[es]Aid Discovery",
                "Subtitle": "[es]More than half of the genes underlying rare diseases remain undiscovered.",
                "Text": "[es]By participating in the Rare Genomes Project, you can help researchers identify the genes that cause rare disease. If you are eligible for the study, we will use genomic sequencing to look for the cause of the rare, undiagnosed disease in your family.",
                "Alt": "[es]Aid Discovery"
            },
            "Answers": {
                "Title": "[es]Find Answers",
                "Subtitle": "[es]Your family’s diagnosis belongs to you.",
                "Text": "[es]If we find a genetic change that may be the cause of the rare disease in your family, we will confirm it in a clinical lab and work with your local doctor to return the result to you.",
                "Alt": "[es]Find Answers"
            },
            "Involved": {
                "Title": "[es]Get Involved",
                "Subtitle": "[es]Join the research community.",
                "Text": "[es]The Rare Genomes Project is supported by The Broad Institute of MIT and Harvard in partnership with patients and advocates like you. We believe that families should be at the center of research involving their diseases, and encourage the involvement of families and the advocacy groups that support them throughout the study.",
                "Alt": "[es]Get Involved"
            },
            "Data": {
                "Title": "[es]Share Data",
                "Subtitle": "[es]Data sharing is crucial for improving diagnosis rates of rare disease worldwide.",
                "Text1": "[es]The genetic information generated in this project will be shared with other scientists to ensure it has the widest possible impact. Your genetic data can help families like yours and improve scientists’ understanding of rare disease. Learn more about our data sharing policies",
                "Text2": "[es]here",
                "Alt": "[es]Share Data"
            }
        },
        "Steps": {
            "Title": "[es]How you can participate",
            "One": {
                "Title": "[es]Tell us your story",
                "Text1": "[es]Click",
                "Text2": "[es]apply",
                "Text3": "[es]to see a broad overview of the study and learn how you can start an application where you can tell us about the history of rare disease in your family. The information will be reviewed by our study team, and eligible families will be invited to participate. We will contact you to arrange a detailed discussion about the study and send you a consent form.",
                "Alt": "[es]Tell us your story"
            },
            "Two": {
                "Title": "[es]Submit a sample",
                "Text": "[es]Once enrolled, we will mail a pre-paid sample collection kit directly to you and your family. We will also ask you more about medical history and ask for copies of medical records, including any prior genetic test results.",
                "Alt": "[es]Share your data"
            },
            "Three": {
                "Title": "[es]Discover",
                "Text": "[es]Through DNA sequencing, we may discover the genetic cause of the rare disease in your family and will work with you and your doctor to return important results to you. We will also share de-identified data broadly with the scientific community to empower discoveries in rare disease research.",
                "Alt": "[es]Discover"
            }
        },
        "Quote": {
            "Text1": "[es]\"This research project really understands the importance of bringing patients in as partners and engaging patients in a novel way. It's critical to do that because",
            "Text2": "[es]patients are often the ones that start driving the research",
            "Author": "[es]-Matt Might, Caregiver and Director, Hugh Kaul Precision Medicine Institute"
        },
        "Partners": {
            "Title": "[es]Our advocacy partners",
            "NOFRDD": "[es]National Organization for Rare Disorders",
            "SWAN": "[es]Syndromes without a Name",
            "Rare": "[es]Rare science accelerating cures for rare kids",
            "RUNMyDNA": "[es]Run my DNA",
            "SBD": "[es]Same but Different",
            "UROurHope": "[es]UR Our Hope",
            "AOA": "[es]Aware of Angels",
            "SNS": "[es]Sweet Nectar Society",
            "RUN": "[es]Rare Undiagnosed Network",
            "MDA": "[es]Muscular Dystrophy Association",
            "GlobalGenes": "[es]Global Genes",
            "MyGene2": "[es]My Gene 2",
            "PatientWorthy": "[es]Patient Worthy",
            "TGPP": "[es]The Giving Picture Project"
        },
        "LastSection": {
            "Title": "[es]You can be the driving force behind rare disease research.",
            "Text": "[es]Many thanks to the National Institutes of Health (NIH), the Muscular Dystrophy Association (MDA), Illumina, Inc., Broad Institute, the Silicon Valley Community Foundation, and Shriners Hospitals for Children for their financial support of our project."
        }
    },
    "AboutUsPage": {
        "Title": "[es]About Us",
        "ImageAlt": "[es]About Us image",
        "Intro": {
            "Paragraph": "[es]The Rare Genomes Project at the Broad Institute of MIT and Harvard is a team of researchers, physicians, software developers, genetic counselors, and study coordinators who believe that the latest advances in genomic sequencing are changing medicine and should be more broadly available to families with rare and undiagnosed conditions."
        },
        "OurStory": {
            "Title": "[es]Our Story",
            "Paragraph1": "[es]The Rare Genomes Project was developed to provide access to genomic research to patients across the United States who are living with undiagnosed, suspected genetic conditions, and to engage with them as partners in the research process.",
            "Paragraph2": "[es]Improving the understanding of rare genetic conditions requires combining genomic research with the experiences of patients and families and sharing this data with the research community. We hope to turn genomic data into clinically meaningful answers for families participating in the project as we advance scientific understanding of rare genetic disorders."
        },
        "BroadInstitute": {
            "Title": "[es]Broad Institute",
            "Paragraph": "[es]The Broad Institute of MIT and Harvard is a non-profit academic research institution in Cambridge, Massachusetts and is focused on using genomic data to better understand human health and disease. The Broad Institute conducts genomic sequencing and research for many projects, and has sequenced over 200,000 human genomes and 500,000 human exomes to date. One of the projects, led by Drs. Heidi Rehm and Daniel MacArthur in collaboration with other researchers, has led to the diagnosis of over 2,000 families with rare disease through genomic sequencing. In 2017, Drs. Rehm and MacArthur created the Rare Genomes Project to bring these resources directly to families."
        },
        "OurTeam": {
            "Title": "[es]Our Team",
            "Leadership": {
                "Title": "[es]Leadership",
                "Members": [
                    {
                        "name": "[es]Heidi Rehm",
                        "degree": "[es]PhD, FACMG",
                        "position": "[es]Principal Investigator",
                        "bio": "[es]Heidi is principal investigator of the Rare Genomes Project and the co-director for the Broad Institute Center for Mendelian Genomics. She is also the chief genomics officer of the Department of Medicine at Massachusetts General Hospital and a professor at Harvard Medical School. She built the Laboratory for Molecular Medicine at Partners HealthCare Personalized Medicine and directed it until 2018. She is a strong advocate and pioneer of open science and data sharing through leadership roles in the Clinical Genome (ClinGen) Resource and the Global Alliance for Genomics and Health.",
                        "image": "heidi-rehm.jpg"
                    },
                    {
                        "name": "[es]Anne O’Donnell-Luria",
                        "degree": "[es]MD, PhD",
                        "position": "[es]Medical Director",
                        "bio": "[es]Anne is the medical director of the Rare Genomes Project and the co-director for the Broad Institute Center for Mendelian Genomics. She obtained her MD/PhD from Columbia University and is a board-certified clinical genetics and metabolism physician and pediatrician who sees patients at Boston Children's Hospital. She is an  assistant professor at Harvard Medical School.",
                        "image": "anne-odonnel.jpg"
                    },
                    {
                        "name": "[es]Melanie O’Leary",
                        "degree": "[es]MS, CGC",
                        "position": "[es]Operations Lead",
                        "bio": "[es]Melanie is the operations lead for the Rare Genomes Project and a principal clinical genomics specialist at the Broad Institute. She oversees the operational aspects of the project. She is a licensed, board-certified genetic counselor who has worked in a variety of clinical, research, and clinical laboratory settings.",
                        "image": "melanie-oleary.jpg"
                    }
                ]
            },
            "ProjectManagement": {
                "Title": "[es]Project Management and Family Engagement",
                "Members": [
                    {
                        "name": "[es]Brian Mangilog",
                        "degree": "",
                        "position": "[es]Clinical Project Coordinator",
                        "bio": "[es]Brian is a clinical project coordinator for the Rare Genomes Project, focusing on consenting families to the study and outreach efforts. He studied neurobiology as an undergraduate and has experience in patient advocacy and community outreach.",
                        "image": "brian-mangilog.jpeg"
                    },
                    {
                        "name": "[es]Grace VanNoy",
                        "degree": "[es]MS, CGC",
                        "position": "[es]Clinical Project Manager",
                        "bio": "[es]Grace is a clinical project manager for the Rare Genomes Project. She is a licensed, board-certified genetic counselor with a background in pediatric rare disease, gene discovery, and genomic sequencing.",
                        "image": "grace-vannoy.jpg"
                    }
                ]
            },
            "LeftColumn": [
                {
                    "Title": "[es]Collaborators",
                    "Members": [
                        {
                            "name": "[es]Carsten Bönnemann",
                            "degree": "[es]MD",
                            "position": "[es]Collaborator",
                            "bio": "[es]Carsten is a neuromuscular physician and senior investigator and chief of the neuromuscular and neurogenetic disorders of childhood section of the National Institute of Neurological Disorders and Stroke (NINDS). His work aims to identify the genetic and cellular mechanisms of early onset muscle diseases, such as the congenital muscular dystrophies, congenital myopathies, and reducing body myopathy.",
                            "image": "carsten-bonnemann.jpeg"
                        },
                        {
                            "name": "[es]Monkol Lek",
                            "degree": "[es]PhD",
                            "position": "[es]Collaborator",
                            "bio": "[es]Monkol is a co-investigator of the limb-girdle muscular dystrophy branch of the Rare Genomes Project and an assistant professor of genetics at Yale School of Medicine with affiliation at the Broad Institute. His group focuses on the development of computational methods for the analysis of genomic data from families with rare disease, particularly those with limb-girdle muscular dystrophy.",
                            "image": "monkol-lek.jpeg"
                        },
                        {
                            "name": "[es]Eric Liao",
                            "degree": "[es]MD, PhD",
                            "position": "[es]Collaborator",
                            "bio": "[es]Eric is a plastic and reconstructive surgeon at Massachusetts General Hospital and co-investigator of the craniofacial branch of the Rare Genomes Project. He is an assistant professor of surgery at Harvard Medical School, the director of the Cleft and Craniofacial Center at Massachusetts General Hospital, and the principal investigator at the Center for Regenerative Medicine at the Harvard Stem Cell Institute.",
                            "image": "eric-liao.jpg"
                        },
                        {
                            "name": "[es]Daniel MacArthur",
                            "degree": "[es]PhD",
                            "position": "[es]Investigator",
                            "bio": "[es]Daniel was the founding principal investigator of the Rare Genomes Project and also served as the co-director for the Broad Institute Center for Mendelian Genomics from 2016-2019. In 2020, he relocated to Sydney, Australia, where he now serves as the Director of the Centre for Population Genomics, jointly based at the Garvan Institute of Medical Research and the Murdoch Children's Research Institute. He is a strong advocate for and pioneer of open science and data sharing. He led the creation and release of the Exome Aggregation Consortium (ExAC) and Genome Aggregation Database (gnomAD).",
                            "image": "daniel-mac-arthur.jpg"
                        }
                    ]
                },
                {
                    "Title": "[es]Software",
                    "Members": [
                        {
                            "name": "[es]Larry Babb",
                            "degree": "",
                            "position": "[es]Senior Software Engineer",
                            "bio": "[es]Larry is a software engineer interested in advancing the use of genetics in both research and clinical care by developing infrastructure for capturing and sharing genetic knowledge using FAIR principles. He manages two software development teams at the Broad Institute, ClinGen and Seqr, and participates in the data sharing standards organizations of GA4GH and HL7. He has worked on both academic and commercial systems for delivering clinical genetics results and knowledge for over 16 years.",
                            "image": "larry-babb.jpeg"
                        },
                        {
                            "name": "[es]Steve Jahl",
                            "degree": "",
                            "position": "[es]Software Engineer",
                            "bio": "[es]Steve is a Site Reliability Engineer working on the stability and performance of our web-based research platforms. Before joining the Broad Institute, he worked as a software engineer and systems administrator in research computing groups at MIT CSAIL and Harvard Medical School.",
                            "image": "steve-jahl.jpg"
                        },
                        {
                            "name": "[es]Hana Snow",
                            "degree": "",
                            "position": "[es]Software Engineer",
                            "bio": "[es]Hana is a software engineer working on building tools to facilitate rare disease research. She is the lead developer for our rare disease analysis platform, seqr.",
                            "image": "hana-snow.jpg"
                        },
                        {
                            "name": "[es]Shifa Zhang",
                            "degree": "[es]MS",
                            "position": "[es]Software Engineer",
                            "bio": "[es]Shifa is a computational scientist and software engineer working on tools for managing and interpreting DNA sequencing data. Prior to joining the Broad Institute, Shifa developed a secure biomedical data analytics and sharing platform at Secure AI Labs.",
                            "image": "shifa-zhang.jpeg"
                        }
                    ]
                }
            ],
            "CenterColumn": [
                {
                    "Title": "[es]Analysis",
                    "Members": [
                        {
                            "name": "[es]Christina Austin-Tse",
                            "degree": "[es]PhD",
                            "position": "[es]Analysis Lead",
                            "bio": "[es]Chrissy is the analysis lead for the Rare Genomes Project, an assistant laboratory director at the Mass General Brigham Laboratory for Molecular Medicine, a Molecular Geneticist at the Massachusetts General Hospital Center for Genomic Medicine, and an Instructor in Pathology at Harvard Medical School. She is a board-certified clinical molecular geneticist who specializes in the interpretation of genomic sequencing data.",
                            "image": "christina-austin-tse.jpg"
                        },
                        {
                            "name": "[es]Stephanie DiTroia",
                            "degree": "[es]PhD",
                            "position": "[es]Genomic Analyst",
                            "bio": "[es]Stephanie is a genomic variant analyst working to identify causal candidate genes and variants in rare disease exomes and genomes. Prior to joining the Broad Institute, she studied epigenetics in fetal development at the University of California, San Francisco and worked in genomic research at the HudsonAlpha Institute for Biotechnology.",
                            "image": "stephanie-di-troia.jpeg"
                        },
                        {
                            "name": "[es]Vijay Ganesh",
                            "degree": "[es]MD, PhD",
                            "position": "[es]Clinical Genomic Analyst",
                            "bio": "[es]Vijay is a clinical genomic analyst and postdoctoral fellow interested in understanding the genetic architecture of adult-onset Mendelian muscle diseases, and incorporating tools such as RNA sequencing to improve the rate of diagnostic in these conditions. He is a board-certified neurologist at Brigham and Women's Hospital where he sees patients with neuromuscular disorders.",
                            "image": "vijay-ganesh.jpeg"
                        },
                        {
                            "name": "[es]Gabrielle Lemire",
                            "degree": "[es]MD, FRCPC",
                            "position": "[es]Clinical Genomic Analyst",
                            "bio": "[es]Gabrielle is a Clinical Genomic Variant Analyst who performs exome and genome analyses for families with rare disease. She is a board-certified Canadian medical geneticist who previously worked with the Care4Rare research program and is now pursuing a postdoctoral fellowship at the Broad Institute.",
                            "image": "gabrielle-lemire.jpeg"
                        },
                        {
                            "name": "[es]Emily O’Heir",
                            "degree": "",
                            "position": "[es]Genomic Analyst",
                            "bio": "[es]Emily is a genomic variant analyst conducting exome and genome analyses for families with rare diseases. She has a degree in diagnostic genetic sciences and previously worked in clinical cytogenetics and genomics laboratories.",
                            "image": "emily-oheir.jpeg"
                        },
                        {
                            "name": "[es]Lynn Pais",
                            "degree": "[es]MS",
                            "position": "[es]Genomic Analyst",
                            "bio": "[es]Lynn is a genomic variant analyst who performs exome and genome analyses for families with rare disease. She has a master’s degree in human genetics and previously worked as a project manager for a genetic research study at Brigham and Women’s Hospital.",
                            "image": "lynn-pais.jpg"
                        },
                        {
                            "name": "[es]Ellie Seaby",
                            "degree": "[es]MD, PhD",
                            "position": "[es]Clinical Genomic Analyst",
                            "bio": "[es]Ellie is a clinical research fellow undertaking a PhD in genomic medicine at the University of Southampton in collaboration with the Broad Institute and Imperial College London. Her research focuses on the discovery of novel disease genes and improving clinical outcomes.",
                            "image": "ellie-seaby.jpeg"
                        },
                        {
                            "name": "[es]Monica Wojcik",
                            "degree": "[es]MD",
                            "position": "[es]Clinical Genomic Analyst",
                            "bio": "[es]Monica is a clinical genomic analyst and a board-certified faculty neonatologist and geneticist at Boston Children’s Hospital. She is interested in gene discovery and improving genetic diagnosis, especially in neonatal and pediatric populations. She has a medical degree from Harvard Medical School.",
                            "image": "monica-wojcik.jpg"
                        }
                    ]
                }
            ],
            "RightColumn": [
                {
                    "Title": "[es]Data Management",
                    "Members": [
                        {
                            "name": "[es]Samantha Baxter",
                            "degree": "[es]MS, CGC",
                            "position": "[es]Associate Director, Genetic and Genomic Data Sharing",
                            "bio": "[es]Sam is a licensed, board-certified genetic counselor and associate director of genetic and genomic data sharing in the Translational Genomics Group at the Broad Institute. This role includes managing the operations for <a href=\"https://gnomad.broadinstitute.org/\" class=\"Link\" target=\"_blank\">gnomAD</a>, overseeing all of the data sharing activities for the <a href=\"https://cmg.broadinstitute.org/\" class=\"Link\" target=\"_blank\">Broad’s Center for Mendelian Genomics</a>, and leading a team of variant curators.  As part of her ongoing research, she uses various curation processes to estimate the prevalence of rare disease in the global population.",
                            "image": "samantha-baxter.jpg"
                        },
                        {
                            "name": "[es]Kayla Delano",
                            "degree": "",
                            "position": "[es]Project Coordinator",
                            "bio": "[es]Kayla is a Project Coordinator for the Center for Mendelian Genomics and Rare Genomes Project. This is her second role at the Broad Institute; prior to this she was working as a research associate in the Infectious Disease and Microbiome program.",
                            "image": "kayla-delano.png"
                        },
                        {
                            "name": "[es]Stacey Hall",
                            "degree": "[es]MPH",
                            "position": "[es]Project Coordinator",
                            "bio": "[es]Stacey is a project coordinator for the Center for Mendelian Genomics and the Rare Genomes Project. She has a masters in public health and prior to working at the Broad she worked in clinical trials research.",
                            "image": "stacey-hall.jpeg"
                        },
                        {
                            "name": "[es]Stacy-Ann Mano",
                            "degree": "[es]MS",
                            "position": "[es]Senior Project Coordinator",
                            "bio": "[es]Stacy is a senior project manager for the Center for Mendelian Genomics and the Rare Genomes Project. Prior to the Broad Institute, Stacy worked in project coordination and management at both research and clinical institutions.",
                            "image": "stacy-ann-mano.jpeg"
                        },
                        {
                            "name": "[es]Moriel Singer-Berk",
                            "degree": "[es]MS",
                            "position": "[es]Genomic Variant Curator",
                            "bio": "[es]Moriel is a genomic variant curator working to assess the pathogenicity of variants for both clinical and research purposes. Prior to joining the Broad Institute, she received her Master's degree in Animal Biology with a focus in equine genetics at the University of California - Davis.",
                            "image": "moriel-singer-berk.png"
                        }
                    ]
                },
                {
                    "Title": "[es]Computational Methods",
                    "Members": [
                        {
                            "name": "[es]Katherine Chao",
                            "degree": "",
                            "position": "[es]Associate Computational Scientist",
                            "bio": "[es]Katherine is an associate computational biologist working on developing computational methods to aid rare disease diagnosis. She also performs exome copy number variant (CNV) calling and conducts exome and genome analyses for the Broad Center for Mendelian Genomics. Before joining the Broad Institute, she worked in the Undiagnosed Diseases program at the National Institutes of Health.",
                            "image": "katherine-chao.jpg"
                        },
                        {
                            "name": "[es]Julia Goodrich",
                            "degree": "[es]PhD",
                            "position": "[es]Computational Scientist",
                            "bio": "[es]Julia is a computational biologist developing methods for the analysis of large-scale genomic datasets including the Genome Aggregation Database (gnomAD) and UK Biobank. She was previously a postdoctoral fellow in the MacArthur lab researching incomplete penetrance in monogenic metabolic conditions.",
                            "image": "julia-goodrich.jpg"
                        },
                        {
                            "name": "[es]Kristen Larrichia",
                            "degree": "[es]MS",
                            "position": "[es]Senior Associate Computational Scientist",
                            "bio": "[es]Kristen is an associate computational biologist who works on methods to identify variants in the mitochondrial genome with the goal of improving rare disease diagnosis.",
                            "image": "kristen-larrichia.jpg"
                        },
                        {
                            "name": "[es]William Phu",
                            "degree": "",
                            "position": "[es]Associate Computational Scientist",
                            "bio": "[es]William is an associate computational biologist investigating unannotated genes and their role in rare diseases. He also contributes to the Genome Aggregation Database (gnomAD) project.",
                            "image": "william-phu.jpg"
                        },
                        {
                            "name": "[es]Ben Weisburd",
                            "degree": "",
                            "position": "[es]Computational Scientist",
                            "bio": "[es]Ben is a computational scientist working on methods and tools for interpreting DNA sequencing data in the context of severe Mendelian diseases with a focus on short tandem repeats and RNA-seq.",
                            "image": "ben-weisburd.jpg"
                        },
                        {
                            "name": "[es]Michael Wilson",
                            "degree": "",
                            "position": "[es]Associate Computational Scientist",
                            "bio": "[es]Mike is an associate computational biologist working on the preliminary analyses of exomes and genomes to identify causal candidate genes and variants. He processes and quality checks the data that is generated for analysis.",
                            "image": "michael-wilson.jpg"
                        }
                    ]
                }
            ]
        },
        "ThankYou": "[es]We thank our friends at the Broad Institute's <a class=\"Link Accent\" href=\"https://www.broadinstitute.org/data-sciences-platform\" target=\"_blank\">Data Donation Platform</a> for their critical design, engineering, and technical work on this project. Raregenomes.org is powered by the DDP's direct-to-patient study recruitment software.",
        "Outro": "[es]Many of the patient and family portraits on our website were photographed by Season Atwater, founder of <a class=\"Link\" href=\"http://awareofangels.org/\" target=\"_blank\">Aware of Angels</a>. Thank you, Season, for being an amazing advocate for the rare disease community, and thank you to all of the families who so kindly shared their photos with us."
    },
    "FaqPage": {
        "Title": "[es]Frequently Asked Questions",
        "Intro": {
            "Text1": "[es]Browse through these FAQs to find answers to commonly raised questions. We also encourage you to read through the other pages of this website. If your question is not answered, please reach out to us by email at",
            "Text2": "[es]or by phone at"
        },
        "General": {
            "Title": "[es]General Questions",
            "Questions": [
                {
                    "question": "[es]What is the goal of The Rare Genomes Project?",
                    "answers": [
                        "[es]The goal of the Rare Genomes Project is to discover the genes underlying undiagnosed rare, genetic conditions by providing families affected by rare disease access to whole genomic sequencing."
                    ]
                },
                {
                    "question": "[es]What does \"undiagnosed\" mean?",
                    "answers": [
                        "[es]For our project, we use this term to mean “<span class=\"Accent\">genetically</span> undiagnosed.” Genetically undiagnosed patients do not have a genetic change(s) identified that explains their symptoms. These patients may or may not have a <span class=\"Accent\">clinical diagnosis</span>, which is based on symptoms and other types of medical test results.",
                        "[es]For example, individuals are most often diagnosed with cystic fibrosis based on physical symptoms and a sweat test. This is a <span class=\"Accent\">clinical diagnosis</span>. Having genetic testing that identifies two variants in the <span class=\"Italic\">CFTR</span> gene that cause cystic fibrosis is a <span class=\"Accent\">genetic diagnosis</span>."
                    ]
                },
                {
                    "question": "[es]Who is conducting the research?",
                    "answers": [
                        "[es]The Rare Genomes Project was launched at the Broad Institute of MIT and Harvard by researchers Daniel MacArthur, PhD and Heidi Rehm, PhD. We are also working in collaboration with Monkol Lek, PhD from Yale University, Eric Liao, MD from Massachusetts General Hospital, Carsten Bonnemann, MD from NIH, and the Lab for Molecular Medicine at Partners HealthCare Center for Personalized Medicine.",
                        "[es]Our team is made up of researchers, physicians, software developers, genetic counselors, and study coordinators. Learn more about us <a href=\"/about-us\" class=\"Link\">here</a>."
                    ]
                }
            ]
        },
        "Before": {
            "Title": "[es]Before You Apply",
            "Questions": [
                {
                    "question": "[es]Do I have to travel to the Rare Genomes Project office in Massachusetts to participate?",
                    "answers": [
                        "[es]No. Participation is entirely remote."
                    ]
                },
                {
                    "question": "[es]Are there any costs to participate?",
                    "answers": [
                        "[es]There are no costs to you to participate in this study. Everything you need to participate, including the cost of sample collection, genomic sequencing, and clinical confirmation genetic testing, will be covered by us."
                    ]
                },
                {
                    "question": "[es]Will I receive medical care and/or treatment from the Rare Genomes Project?",
                    "answers": [
                        "[es]No. Medical care and treatment will not be provided as part of this research study."
                    ]
                },
                {
                    "question": "[es]What role does my medical provider play in this study?",
                    "answers": [
                        "[es]While we do not require involvement in the application process, a family's clinician can help individuals identify pertinent medical records and is also critical in partnering with us to clinically confirm and return results to families."
                    ]
                },
                {
                    "question": "[es]What type of sample will I be asked for?",
                    "answers": [
                        "[es]We request one small tube of blood. In rare cases, we have worked with families to explore alternative sample types."
                    ]
                },
                {
                    "question": "[es]What type of genetic testing is performed by the Rare Genomes Project offering?",
                    "answers": [
                        "[es]The Rare Genomes Project offers Whole Genome Sequencing (WGS). WGS is a different test than Whole Exome Sequencing (WES), which is a more focused test that is more commonly covered by insurance companies. Sometimes, we may perform additional tests including Structural Variant Analysis and RNAseq. To learn more about WGS and other types of genetic testing, we recommend reading through Genetics Home Reference's <a href=\"https://ghr.nlm.nih.gov/primer#testing\" target=\"_blank\" class=\"Link\">website</a>."
                    ]
                },
                {
                    "question": "[es]I have already had whole genome sequencing. Will the Rare Genomes Project accept my external data for reanalysis?",
                    "answers": [
                        "[es]On a case-by-case basis. If you have had prior genomic sequencing, fill out an application to our study and indicate that you have prior sequencing data available. If your application is accepted, we will reach out to you and discuss the next steps. Due to the resources involved in obtaining and manipulating data from other sources, it is sometimes more time and cost effective for us to sequence your genome again."
                    ]
                }
            ]
        },
        "Process": {
            "Title": "[es]The Application Process",
            "Questions": [
                {
                    "question": "[es]Who should apply to participate?",
                    "answers": [
                        "[es]Patients and families with rare, suspected genetic disease. To see if the Rare Genomes Project might be appropriate for your family, visit our <a href=\"/eligibility-criteria\" class=\"Link\">Eligibility Criteria</a> page for more detailed information."
                    ]
                },
                {
                    "question": "[es]Can I apply if I live outside the United States?",
                    "answers": [
                        "[es]We currently are only able to enroll individuals that live in the United States. However, we hope to eventually expand the project. If you live outside the United States and are interested in participating, we encourage you to indicate on our <a href=\"/count-me-in\" class=\"Link\">application page</a> that you do not live in the United States and then join our mailing list on the following page when prompted. We will contact you if we change our participation requirements in the future."
                    ]
                },
                {
                    "question": "[es]Who in my family should participate?",
                    "answers": [
                        "[es]The nature of this project requires that the person in your family with an undiagnosed genetic condition participate. Although not a requirement, having additional family members participate, especially both of the patient's biological parents and additional affected family members, improves our chances of finding the genetic cause of the rare, undiagnosed condition. For example, a study of whole exome sequencing showed that analysis of parents along with affected children increased the likelihood of diagnosis from 22% to 31% (<a href=\"https://jamanetwork.com/journals/jama/fullarticle/1918775\" target=\"_blank\" class=\"Link\">Lee et al. 2014</a>)."
                    ]
                },
                {
                    "question": "[es]Can I still apply to the Rare Genomes Project if the affected family member is adopted, or one biological parent is unavailable?",
                    "answers": [
                        "[es]Yes. In cases where one biological parent is unavailable, we may ask about the availability of their other relatives."
                    ]
                },
                {
                    "question": "[es]If I complete an application, will I automatically be able to participate?",
                    "answers": [
                        "[es]No. Our clinical team reviews each application to determine whether the individual or family is a good fit for this study. In some cases, we may need to review your medical records in order to make a determination. To learn more, visit our <a href=\"/eligibility-criteria\" class=\"Link\">Eligibility Criteria</a> page."
                    ]
                },
                {
                    "question": "[es]Why was my application to the Rare Genomes Project not accepted?",
                    "answers": [
                        "[es]There are many reasons an application may not be accepted. Some reasons include: the condition is not likely to be caused by a change in a single gene, the approach taken by our study is not likely to diagnose the condition in question, or we believe a genetic diagnosis has already been identified. You can read more about our eligibility criteria <a href=\"/eligibility-criteria\" class=\"Link\">here</a>."
                    ]
                }
            ]
        },
        "Collection": {
            "Title": "[es]Collection of Data and DNA",
            "Questions": [
                {
                    "question": "[es]How and where do I get my blood drawn?",
                    "answers": [
                        "[es]We will mail you a pre-paid specimen collection kit for you to have your blood drawn at a location of your choosing. We have partnered with Quest Diagnostics, a company with <a href=\"https://appointment.questdiagnostics.com/patient/confirmation\" target=\"_blank\" class=\"Link\">thousands of blood draw locations</a> across the United States and Puerto Rico, who will draw blood for the study and bill us directly. Alternatively, you can have your blood drawn by a local provider. If you are billed for this, send us a receipt for reimbursement."
                    ]
                },
                {
                    "question": "[es]What happens after I return my blood kit?",
                    "answers": [
                        "[es]After your kit returns to our facilities, we will extract DNA from your blood sample and prepare it for DNA sequencing or targeted testing."
                    ]
                },
                {
                    "question": "[es]Who in my family will get their genome sequenced?",
                    "answers": [
                        "[es]It depends. Typically, we perform genome sequencing on the affected individual(s) in the family and their biological parents (when available). We typically only perform targeted testing for specific variants of interest in unaffected family members."
                    ]
                },
                {
                    "question": "[es]What else might I be asked to share if I participate in this project?",
                    "answers": [
                        "[es]We require medical records from the affected family member(s). We may also inquire about the availability of excess tissue from clinical procedures for additional testing. Because this study does not include a physical examination by study staff, we will also ask participants to share a photograph; this is optional."
                    ]
                },
                {
                    "question": "[es]Why am I being asked for photographs?",
                    "answers": [
                        "[es]We routinely ask for photographs of the member of the family with the undiagnosed condition. Some genetic syndromes are known to cause characteristic or subtle facial features that we consider when determining if a participant’s condition is related to a genetic variant. Photographs are considered part of the patient’s medical record and will not be shared externally without permission."
                    ]
                },
                {
                    "question": "[es]When should I update study staff?",
                    "answers": [
                        "[es]It is important to contact us if you change your contact information (such as phone number or address) or have new medical information you wish to add to your file (such as a new symptom, a genetic diagnosis from another source, or the development of the condition in other family members.)"
                    ]
                },
                {
                    "question": "[es]Can I withdraw from the project?",
                    "answers": [
                        "[es]Yes, you can withdraw from the project at any time. If you do, your samples and your information will be destroyed. However, it will not be possible to destroy samples and information that have already been shared with other researchers. If you decide to withdraw your permission, you should contact us in writing at <a href=\"mailto:raregenomes@broadinstitute.org\" class=\"Link\">raregenomes@broadinstitute.org</a>."
                    ]
                }
            ]
        },
        "Return": {
            "Title": "[es]Return of Results",
            "Questions": [
                {
                    "question": "[es]Will I receive results?",
                    "answers": [
                        "[es]Our goal is to find the genetic explanation for the undiagnosed condition in each family who enrolls, but we cannot guarantee a result for each family. If we are able to find a genetic cause of your condition, we will work with the medical provider of your choice to return results that are known or suspected to be related to the rare disease in the family."
                    ]
                },
                {
                    "question": "[es]Will I receive results unrelated to the rare condition for which I applied?",
                    "answers": [
                        "[es]We do not actively search for genetic results unrelated to the rare condition in the family. However, if we find a variant that causes a condition with treatment implications, we will provide the option of clinically confirming the result to have it returned."
                    ]
                },
                {
                    "question": "[es]How will I receive my results?",
                    "answers": [
                        "[es]You can only receive results that have been confirmed in a Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory. If we find results that we believe may explain the underlying cause of the rare condition present in your family, we will contact you and ask if you would like to have the findings clinically confirmed in a CLIA-certified laboratory. A genetic counselor on our staff will work with a doctor of your choice to order testing through the CLIA lab."
                    ]
                }
            ]
        },
        "Data": {
            "Title": "[es]Data Generation and Usage",
            "Questions": [
                {
                    "question": "[es]How will my genetic data be shared?",
                    "answers": [
                        "[es]One of the goals of this project is to improve rare disease diagnosis for participants and the rare disease community as a whole. Data sharing supports this goal by allowing researchers and clinicians around the world to access the de-identified genetic data generated in our project. Learn more about how we share de-identified data <a href=\"/privacy-and-your-data\" class=\"Link\">here</a>."
                    ]
                },
                {
                    "question": "[es]Can I have access to my genetic sequencing data?",
                    "answers": [
                        "[es]Unfortunately, no. Because the genomic sequencing in this study will be performed in a research laboratory (non-CLIA laboratory), federal regulations prohibit us from directly releasing your individual raw sequencing data to you."
                    ]
                },
                {
                    "question": "[es]Can outside researchers access data generated as part of this project?",
                    "answers": [
                        "[es]Yes. If you are a researcher looking for more information, please visit our data sharing <a href=\"/data-sharing\" class=\"Link\">page</a>."
                    ]
                },
                {
                    "question": "[es]Can outside researchers request samples from this study for use in their own research?",
                    "answers": [
                        "[es]In some cases, we may share de-identified samples with external collaborators. Please contact us to learn more"
                    ]
                },
                {
                    "question": "[es]Can outside researchers submit a cohort of samples be sequenced through this project?",
                    "answers": [
                        "[es]While the Rare Genomes Project works directly with patients, the Broad Center for Mendelian Genomics (CMG) may be interested in collaborating with external researchers. To learn more, visit the CMG's <a href=\"https://cmg.broadinstitute.org\" target=\"_blank\" class=\"Link\">website</a>."
                    ]
                }
            ]
        },
        "Spread": {
            "Title": "[es]Spreading the Word about RGP",
            "Questions": [
                {
                    "question": "[es]How can I refer families with rare and undiagnosed genetic conditions to this project?",
                    "answers": [
                        "[es]If you are a family involved in the Rare Genomes Project and know other families who might benefit from participation, please direct them to our website or have them contact us at <a href=\"mailto:raregenomes@broadinstitute.org\" class=\"Link\">raregenomes@broadinstitute.org</a>. If you would like to share your participation with others, feel free to post the link to our website on your social media pages so that more patients can learn about the project.",
                        "If you are a clinician who cares for a patient you believe could benefit from the Rare Genomes Project, encourage the family to fill out an online application on this website and have them indicate your name when asked about a referring provider."
                    ]
                },
                {
                    "question": "[es]Do you have informational materials for patients and families?",
                    "answers": [
                        "[es]Yes! Please contact us by phone at <a href=\"tel:617-714-7395\" class=\"Link\">617-714-7395</a> or by email at <a href=\"mailto:raregenomes@broadinstitute.org\" class=\"Link\">raregenomes@broadinstitute.org</a> for copies of our materials."
                    ]
                },
                {
                    "question": "[es]Does the Rare Genomes Project work with other organizations?",
                    "answers": [
                        "[es]Yes! We are interested in working with advocacy groups who support families who may benefit from our research. We are also interested in raising awareness of groups that help individuals and families with rare diseases access support, resources, and future research or treatment opportunities. If you are involved with either type of advocacy group, please reach out to us by email at <a href=\"mailto:raregenomes@broadinstitute.org\" class=\"Link\"> raregenomes@broadinstitute.org</a>, or by phone at <a href=\"tel:617-714-7395\" class=\"Link\">617-714-7395</a>."
                    ]
                }
            ]
        }
    },
    "PasswordPage": {
        "PasswordWrongError": "[es]Incorrect password. Please try again.",
        "OtherError": "[es]We're sorry, but an error has occurred.",
        "PasswordRequiredError": "[es]Password is required",
        "SubmitButton": "[es]Submit",
        "Placeholder": "[es]Please enter a password to access the site "
    },
    "EligibilityPage": {
        "Title": "Criterios de idoneidad",
        "Intro": {
            "Text1": "El Proyecto Genomas Raros ofrece secuenciación genómica de investigación a pacientes y familias en quienes se sospecha una enfermedad genética que no se ha diagnosticado. Nuestro equipo revisa atentamente cada solicitud que recibimos para determinar si existe la probabilidad de que en el estudio que realizamos se descubra la causa genética de la enfermedad que se presenta en su familia.",
            "Text2": {
                "Part1": "Aceptamos solicitudes de familias con todo tipo de enfermedades raras. Además, en el Proyecto hay divisiones especializadas que se centran en la",
                "Part2": "distrofia muscular de cinturas",
                "Part3": "y en las",
                "Part4": "enfermedades craneofaciales",
                "Part5": "que se explican en más detalle en las páginas respectivas."
            }
        },
        "Eligible": {
            "Intro": {
                "Text1": "Para participar, el solicitante",
                "Text2": "debe:"
            },
            "List": {
                "Item1": "Tener una enfermedad genética rara que no se haya diagnosticado",
                "Item2": "Vivir en los Estados Unidos",
                "Item3": "Hablar inglés o español",
                "Item4": "Recibir actualmente los cuidados de un profesional médico que le esté ayudando a determinar la causa de la enfermedad",
                "Item5": "Tener acceso a un teléfono o a una computadora"
            },
            "Ending": {
                "Text1": {
                    "Part1": "Los solicitantes",
                    "Part2": "no tienen",
                    "Part3": "que pagar ninguna cuota relacionada con el estudio ni viajar a nuestra oficina de Cambridge (Massachusetts). La participación se realiza completamente a distancia y es gratuita."
                },
                "Text2": {
                    "Part1": "Si no cumple uno o más de estos criterios, le recomendamos que se",
                    "Part2": "inscriba en nuestra lista de correo",
                    "Part3": "Nos comunicaremos con usted si los requisitos cambian y le permiten solicitar el ingreso al estudio."
                }
            }
        },
        "General": {
            "MoreLikely": {
                "Text": {
                    "Part1": "En general, las familias que tienen",
                    "Part2": "más probabilidades",
                    "Part3": "de beneficiarse de la estrategia de este estudio son aquellas en quienes se sospecha que la causa de la enfermedad es un gen único y que tienen algunas de las siguientes características:"
                },
                "List": {
                    "Item1": "Un inicio más precoz que el típico o una presentación grave de los síntomas",
                    "Item2": "Varias personas de la familia afectadas por la misma enfermedad (o por una enfermedad parecida).",
                    "Item3": "Disponibilidad de los padres biológicos de las personas afectadas y que estos padres no tengan la enfermedad",
                    "Item4": "Resultados de algunas pruebas genéticas anteriores que no llevaron a un diagnóstico"
                }
            },
            "LessLikely": {
                "Text": {
                    "Part1": "En general, las familias que tienen",
                    "Part2": "menos probabilidades",
                    "Part3": "de beneficiarse de la estrategia de este estudio son aquellas cuya enfermedad:"
                },
                "List": {
                    "Item1": "Tal vez no se deba a una alteración en un gen único (por ejemplo, el síndrome de Ehlers-Danlos, los defectos cardíacos aislados, la asociación VACTERL y los trastornos autoinmunitarios).",
                    "Item2": "Tenga una causa ambiental presunta o conocida.",
                    "Item3": "Tenga una causa genética ya diagnosticada.",
                    "Item4": "No se haya diagnosticado mediante secuenciación previa del genoma completo."
                }
            },
            "Ending": {
                "Text1": {
                    "Part1": "Si cree que su familia cumple los criterios, le recomendamos que",
                    "Part2": "se entere de cómo presentar su solicitud"
                },
                "Text2": {
                    "Part1": "Escríbanos por correo electrónico a",
                    "Part2": "o llámenos por teléfono al",
                    "Part3": "si tiene preguntas o desea que tengamos en cuenta la solicitud de un caso especial."
                }
            }
        }
    },
    "HowItWorksPage": {
        "Title": "Para comenzar",
        "Intro": {
            "Question": "¿Piensa inscribirse?",
            "Answer": {
                "Text1": "Nos encanta que se interese en nuestro proyecto. Lea estos pasos para saber en qué consiste el Proyecto Genomas Raros. Si cree que el Proyecto Genomas Raros podría ser adecuado para usted, haga clic en",
                "Text2": "Iniciar una solicitud de ingreso",
                "Text3": "en la parte inferior de esta página."
            }
        },
        "CommonAlt": "Para comenzar fotografía",
        "Items": [
            {
                "title": "Conozca el proyecto",
                "text": "El Proyecto Genomas Raros es un estudio clínico que se centra en pacientes y en familias que tienen <span class=\"Accent\">enfermedades raras y de causa genética desconocida</span>. Empleamos la secuenciación del genoma para buscar la causa de la enfermedad rara en estas familias y al mismo tiempo esperamos acelerar la tasa de diagnóstico de estas enfermedades. Si desea más información, revise los <a href=\"/eligibility-criteria\" class=\"Link\">criterios de idoneidad</a> y lea los siguientes pasos.",
                "image": "/assets/images/step-1.jpg"
            },
            {
                "title": "Cuéntenos acerca de su familia",
                "text": "Durante el proceso de solicitud de ingreso le haremos preguntas sobre la enfermedad rara y de presunta causa genética de su familia, le pediremos unos datos demográficos limitados, cierta información sobre los antecedentes médicos familiares y los resultados de las pruebas genéticas y de otro tipo que se hayan realizado. Después de que termine la solicitud, el equipo investigador revisará la información que usted envíe para determinar si sería un participante idóneo para el estudio. Si es así, programaremos una reunión por video o una teleconferencia con usted y su familia para explicarles el estudio y garantizar que se responda a todas sus preguntas. Cada persona de la familia recibirá un documento de consentimiento que debe firmar para participar.",
                "image": "/assets/images/step-2.jpg"
            },
            {
                "title": "Envíenos su historia clínica",
                "text": "Después de firmar los documentos de consentimiento le pediremos copias de las historias clínicas de las personas de la familia afectadas por la enfermedad, en las que deben incluirse los resultados de las pruebas genéticas. Puede enviarnos esta información por correo electrónico o por fax confidencial con los datos que se le entreguen después de la sesión de consentimiento.",
                "image": "/assets/images/step-3.jpg"
            },
            {
                "title": "Envíenos su muestra",
                "text": "Cuando se inscriba, le enviaremos por correo postal estuches de recolección de muestras directamente a usted y a su familia. Puede llevar estos estuches a la sede local de Quest Diagnostics, a un consultorio médico o a un hospital. Nosotros pagamos todas las cuotas relacionadas con la obtención de muestras.",
                "image": "/assets/images/step-4.jpg"
            },
            {
                "title": "La secuenciación del ADN",
                "text": "Cuando su muestra llegue al laboratorio del proyecto, le extraeremos el ADN y realizaremos la secuenciación del genoma. Si desea más información sobre la secuenciación, visite la página correspondiente de <a href=\"https://ghr.nlm.nih.gov/primer/testing/sequencing\" target=\"_blank\" class=\"Link\">Ayúdeme a entender la genética</a> de la Biblioteca Nacional de Medicina (National Library of Medicine).",
                "image": "/assets/images/step-5.jpg"
            },
            {
                "title": "El análisis de los datos genómicos",
                "text": "Para buscar la causa genética de su enfermedad compararemos su genoma con el de cientos de miles de personas que no tienen esa enfermedad y con el de sus familiares. Esto nos permite identificar las variantes de ADN de su genoma que puedan tener relación con la enfermedad.",
                "image": "/assets/images/step-6.jpg"
            },
            {
                "title": "Compartir sus datos",
                "text": "Compartir sus síntomas y sus datos genómicos con otros investigadores y médicos hace que sea más probable encontrar a otras personas que tengan síntomas parecidos y alteraciones en los mismos genes. Puede ver más información sobre las formas en que compartimos sus datos y sobre nuestra política de protección de la privacidad <a href=\"/privacy-and-your-data\" class=\"Link\">aquí</a>.",
                "image": "/assets/images/step-7.jpg"
            },
            {
                "title": "Recibir los resultados que tengan importancia clínica",
                "text": "Si obtenemos resultados que puedan, en nuestra opinión, explicar la causa de su enfermedad rara, nos comunicaremos con usted y le preguntaremos si desea confirmarlos en el laboratorio clínico con el que colaboramos, el Laboratorio de Medicina Molecular de Cambridge (Massachusetts). Si desea hacerlo, nos coordinaremos con usted y con su médico para entregarle los resultados.",
                "image": "/assets/images/step-8.jpg"
            }
        ],
        "Ending": {
            "Start": {
                "Text": "Si le parece que el proyecto podría beneficiarle o beneficiar a uno de sus seres queridos, le recomendamos llenar una solicitud de ingreso por Internet aquí:",
                "Button": "Iniciar una solicitud de ingreso"
            },
            "AnyQuestions": {
                "Question": "¿Aún tiene preguntas?",
                "Text1": "Si no ve su pregunta",
                "Text2": "aquí",
                "Text3": "escríbanos por correo electrónico a",
                "Text4": "o llámenos al"
            }
        }
    },
    "PrivacyAndYourDataPage": {
        "Title": "Su privacidad y sus datos",
        "ImageAlt": "Imagen de intercambio de datos",
        "Intro": "<b>La secuenciación genómica es apenas el primer paso para entender las enfermedades raras</b> &mdash; comunicar sus síntomas y sus datos genómicos a otros investigadores y médicos hace que sea más probable encontrar a otras personas que tengan síntomas parecidos y alteraciones en los mismos genes.",
        "DataSharing": {
            "Title": "¿Qué es compartir los datos?",
            "Text1": "Compartir los datos es intercambiar los datos de secuenciación y ciertos datos clínicos limitados del proyecto con otras personas ajenas a él. Con frecuencia, las personas que desean tener acceso a los datos que producimos en el Proyecto Genomas Raros son otros científicos que se interesan en saber más sobre los aspectos genéticos de una enfermedad o afección específica. Puesto que las enfermedades raras afectan a tan pocas personas, compartir los datos les permite a los científicos de todo el mundo establecer conexiones mutuas y acelerar la velocidad con que se hacen descubrimientos en las enfermedades genéticas.",
            "Text2": "Utilizaremos varias plataformas para compartir sus datos de secuenciación y los síntomas clave de la enfermedad genética rara que hay en su familia. <b>La información que compartimos se desidentifica. Esto significa que su nombre, su fecha de nacimiento, sus datos de contacto y otros datos que revelan su identidad no se comparten nunca.</b>"
        },
        "VariantInformation": {
            "Title": "Cómo compartimos la información sobre variantes",
            "Paragraph1": {
                "Text1": "Compartimos información sobre variantes cuando sospechamos que una variante específica podría ser la causa de una enfermedad rara. La información sobre este tipo de variantes se comunica mediante un recurso en línea llamado",
                "Text2": "Matchmaker Exchange",
                "Text3": "que les permite los investigadores y a los médicos establecer conexiones mutuas. Estas conexiones pueden llevar a colaboraciones que permitan establecer las pruebas de que las variantes y los genes tienen relación con enfermedades raras."
            },
            "Paragraph2": {
                "Text1": "También compartimos información de variantes cuando hemos confirmado que una variante causa una enfermedad rara. En este caso, la información sobre este tipo de variantes se realiza a través de una base de datos pública llamada",
                "Text2": "ClinVar",
                "Text3": "ClinVar es una fuente de referencia que los médicos y los científicos pueden usar para saber qué alteraciones genéticas se han encontrado en pacientes y se han asociado con enfermedades genéticas."
            }
        },
        "GenomicInformation": {
            "Title": "¿Cómo compartimos la información genómica completa?",
            "Text1": "Compartimos los datos completos de la secuenciación del genoma y la información médica resumida en dos plataformas para contribuir a acelerar la velocidad de los descubrimientos científicos. Por ejemplo, los datos se conservan en el Broad Institute y se puede tener acceso a ellos con la aprobación del Sistema de Supervisión del Uso de Datos (Data Use Oversight System, <a class=\"Link\" href=\"https://duos.broadinstitute.org/#/home\" target=\"_blank\">DUOS</a>) de este instituto.",
            "Text2": "Además, compartimos la información en una base de datos parecida y financiada por el gobierno federal, que se llama <a class=\"Link\" href=\"https://www.genome.gov/27569268/genomic-analysis-visualization-and-informatics-labspace-anvil/\" target=\"_blank\">AnVIL</a>. Los investigadores interesados deben solicitar y lograr el acceso a los datos en estas plataformas."
        },
        "Privacy": {
            "Title": "Su privacidad",
            "Text": "Compartir datos es importante para mejorar los conocimientos que se tienen acerca de las enfermedades raras, y tenemos muchos mecanismos de seguridad para asegurar que los datos que obtenemos en el proyecto se conserven de manera segura y se intercambien de un modo responsable. A continuación tenemos unas preguntas frecuentes sobre la privacidad y el empleo de los datos en el Proyecto Genomas Raros."
        },
        "Stored": {
            "Question": "¿Cómo se conservan mis datos?",
            "Answer": "Los datos genéticos y electrónicos (por ejemplo, las historias clínicas electrónicas) se conservan en sistemas seguros y cifrados que pertenecen al Broad Institute y a Partners HealthCare, la organización hospitalaria responsable del proyecto. Sus datos se rotulan con un número de identificación aleatorizado del estudio, al que solo el personal del estudio tiene acceso. Los datos físicos (por ejemplo, las historias clínicas impresas) se conservan bajo llave en un gabinete seguro de la oficina del equipo investigador."
        },
        "Shared": {
            "Question": "¿Mi nombre o mis datos personales se entregarán a otros investigadores y médicos?",
            "Answer": "Nunca. Los datos genéticos que se generan en el proyecto se <b>desidentifican</b>, no contienen información que pueda revelar su identidad, como nombre o fecha de nacimiento."
        },
        "Profit": {
            "Question": "¿El Proyecto Genomas Raros se beneficiará económicamente de mis datos?",
            "Answer": "Nunca. El Proyecto Genomas Raros es un estudio clínico sin fines de lucro y no venderá sus datos genómicos."
        },
        "Ending": {
            "Text1": "Durante la llamada de consentimiento hablaremos de la comunicación de datos si se le acepta en el proyecto y nos cercioraremos de que usted entienda cómo se emplearán sus datos. Si tiene preguntas o dudas sobre su privacidad que no se respondieron en esta página, escríbanos por correo electrónico a",
            "Text2": "o llámenos por teléfono al"
        }
    },
    "ForYourPhysicianPage": {
        "Title": "Para el médico",
        "Intro": "El Proyecto Genomas Raros es un estudio clínico del Broad Institute de MIT y Harvard, una institución de investigación académica sin fines de lucro que se centra en utilizar los datos genómicos para entender mejor la salud y las enfermedades de los seres humanos. Nuestro equipo, dirigido por la investigadora Heidi Rehm, tiene un interés específico en conocer las bases genéticas de enfermedades muy raras y que no se han diagnosticado aún. Nuestra misión es colaborar directamente con los pacientes, las familias, los defensores de los pacientes y los médicos para fomentar el acceso de los pacientes a la investigación genómica.",
        "DownloadPDF": "Descargar el PDF",
        "HowItWorks": {
            "Title": "Cómo funciona",
            "Paragraphs": [
                "El Proyecto Genomas Raros les da a las familias que no han recibido un diagnóstico la oportunidad de participar en un estudio de investigación genómica, independientemente de dónde vivan en los Estados Unidos. Para garantizar que toda familia que cumpla los requisitos pueda participar, todas las técnicas del estudio se pueden realizar desde la casa del paciente o cerca de ella.",
                "Las personas y las familias interesadas pueden visitar <a href=\"http://raregenomes.org\" target=\"_blank\" class=\"Link\">www.raregenomes.org</a> para ver más información sobre el proyecto. Al hacer clic en «Iniciar una solicitud de ingreso» pueden expresar su interés en participar. El equipo clínico revisará cada solicitud e invitará a participar a las familias que cumplan los requisitos para hacerlo.",
                "A las familias que se inscriban les enviaremos un estuche de recolección de muestras para ir a un centro de atención al paciente de Quest Diagnostics (<a href=\"http://questdiagnostics.com/appointment\" target=\"_blank\" class=\"Link\">www.questdiagnostics.com/appointment</a>) o a otro centro de extracción de sangre que elijan. En algunos casos podríamos solicitar ADN de pruebas genéticas anteriores. Los estuches de recolección de muestras se enviarán por correo a nuestro laboratorio, donde se realizarán la extracción del ADN y la secuenciación del genoma.",
                "Nuestro equipo analizará los datos genómicos junto con la información clínica de cada familia con el fin de identificar las bases genéticas de la enfermedad que esta tiene. Si podemos determinar la causa de la enfermedad, nos comunicaremos de nuevo con la familia y trataremos de lograr la confirmación clínica del resultado con la colaboración del médico que esta escoja. El informe de confirmación clínica se enviará al médico local que haya ordenado la prueba.",
                "Este proyecto se compromete al intercambio rápido y abierto de los datos. Los datos genéticos y clínicos desidentificados que se generen en este proyecto se compartirán ampliamente con la comunidad entera de personas afectadas por enfermedades raras y sin diagnosticar, así como con otros médicos e investigadores, a través de bases de datos genómicos de acceso controlado, del Matchmaker Exchange y de Clinvar."
            ]
        },
        "EligibilityCriteria": {
            "Title": "Criterios de idoneidad para las familias",
            "Lists": [
                {
                    "Title": "Pacientes y familias que tengan una enfermedad <span class=\"Accent\">rara cuya causa genética no se haya diagnosticado</span>, y que además:",
                    "Items": [
                        "Hablen inglés o español",
                        "Vivan en los Estados Unidos",
                        "Reciban los cuidados de un médico que les esté ayudando a determinar la causa de la enfermedad"
                    ]
                },
                {
                    "Title": "En este momento no podemos incluir a pacientes ni a familias que:",
                    "Items": [
                        "Tengan una enfermedad cuya causa presunta o conocida sea un factor ambiental",
                        "Tengan una enfermedad que probablemente no sea monogénica",
                        "Tengan un diagnóstico clínico que explique por completo la enfermedad del paciente"
                    ]
                }
            ]
        },
        "Help": {
            "Title": "Cómo remitir a una familia",
            "Text": "Si usted atiende actualmente a familias que considere idóneas para participar en este proyecto, dígales que visiten nuestro sitio web, <a href=\"http://raregenomes.org\" target=\"_blank\" class=\"Link\">www.raregenomes.org</a>. También cooperamos directamente con médicos, hospitales e instituciones para aumentar la concientización acerca del proyecto. Si desea que le proporcionemos folletos y materiales informativos para los pacientes que van a su consultorio, comuníquese con nosotros."
        },
        "Role": {
            "Title": "El papel que usted desempeña en el proyecto",
            "Text1": "Nos interesa colaborar con los médicos de los participantes para facilitar la entrega de los resultados confirmados de importancia clínica que se descubran en el proyecto.",
            "Text2": "Otras formas en las que usted podría participar:",
            "Item1": "Agregar y resumir las historias clínicas y la información clínica de la familia",
            "Item2": "Responder a las preguntas de seguimiento que surjan durante la participación de la familia en el proyecto",
            "ThankYou": "[es]Thank you for your support. We look forward to learning with you!"
        },
        "ThankYou": "Le agradecemos su apoyo. Esperamos aprender muy pronto con usted.",
        "Contact": "Comuníquese con nosotros"
    },
    "DataAccessPage": {
        "Title": "[es]Data Access",
        "ImageAlt": "[es]Data Sharing image",
        "Text": "[es]The Rare Genomes Project is based at the Broad Institute of MIT and Harvard, a non-profit research institution in Cambridge, Massachusetts. The aim of the project is to use genomic sequencing of affected individuals and their family members to identify the genetic causes of rare disease. Our team, led by investigators Drs. Daniel MacArthur and Heidi Rehm, is committed to open science and rapid data sharing, with the hope of improving the rate of rare disease diagnosis through collaborations with other researchers worldwide. De-identified data generated by the project will be shared on the following platforms:",
        "MatchmakerExchange": {
            "Title": "[es]Matchmaker Exchange",
            "Text": "<a href=\"http://www.matchmakerexchange.org/\" class=\"Link\" target=\"_blank\">Matchmaker Exchange</a> (MME) allows researchers, laboratories, and clinicians to submit anonymized genotype and phenotype information to a federated platform of international stakeholders in the hopes of “matching” with others who submitted a case with overlapping clinical symptoms or genetic variants. The Rare Genomes Project enters variants of interest into MME on an ongoing basis. To access MME’s resources, individuals must submit their own cases or datasets to begin matching. To learn more about how to get started with MME’s services, visit their <a href=\"http://www.matchmakerexchange.org/i_am_a_clinician_laboratory.html\" class=\"Link\" target=\"_blank\">website</a>."
        },
        "ClinVar": {
            "Title": "[es]ClinVar",
            "Text": "<a href=\"https://www.ncbi.nlm.nih.gov/clinvar/\" class=\"Link\" target=\"_blank\">ClinVar</a> is a publicly accessible NCBI database that collects and displays information about genetic variants and their relationship to human disease. Clinical laboratories and researchers submit variant information along with the interpretation of its pathogenicity. Reportable variants identified through the project are most often submitted to ClinVar by our clinical partner, the Laboratory for Molecular Medicine. Direct submissions by the Rare Genomes Project are listed under the entry for the <a href=\"https://www.ncbi.nlm.nih.gov/clinvar/submitters/506627/\" class=\"Link\" target=\"_blank\">Broad Institute Rare Disease Group</a>."
        },
        "DUOS": {
            "Title": "[es]DUOS",
            "Text": "[es]The Broad Institute developed the Data Use Oversight System (<a href=\"https://duos.broadinstitute.org/#/home\" class=\"Link\" target=\"_blank\">DUOS</a>) to streamline the sharing of de-identified clinical and genomic sequencing data with the research community. To access data generated by the Rare Genomes Project, researchers may visit the DUOS website, apply for access, and describe how they will use the data for their research study. This request will then be reviewed by the DUOS data access committee, who must review and approve the request before access to the data is granted. Approved researchers will gain access to genomic sequencing data and clinical information from RGP families, but with all personally identifiable information removed. The Rare Genomes Project submits data to DUOS on an ongoing basis under dataset name ‘RGP_MacArthur_RareDisease_WGS’ and ID number DUOS_000008. <span class=\"Accent\">The Rare Genomes Project does not process applications to DUOS. For more information about DUOS or to address questions about your application, please visit DUOS’s <a href=\"https://duos.broadinstitute.org/#/home_help\" class=\"Link Accent\" target=\"_blank\">support page</a>.</span>"
        },
        "AnVIL": {
            "Title": "[es]AnVIL",
            "Text1": "[es]The NHGRI Genomic Data Science Analysis, Visualization, and Informatics Lab-Space (<a href=\"https://www.genome.gov/27569268/genomic-analysis-visualization-and-informatics-labspace-anvil/\" class=\"Link\" target=\"_blank\">AnVIL</a>) is a federally-funded resource for the genomic scientific community that leverages a cloud-based infrastructure for genomic data access, sharing, and computing. AnVIL provides a collaborative environment with user interfaces for datasets and analysis workflows.",
            "Text2": "[es] To access data generated by the Rare Genomes Project, researchers apply for access. Approved researchers will gain access to genomic sequencing data and clinical information from RGP families, but with all personally identifiable information removed. The Rare Genomes Project submits data to AnVIL on an ongoing basis under Broad Institute Center for Mendelian Genomics in the subset workspace AnVIL_CMG_Broad_Rare_RGP_WGS, with ID number phs001272.v2.p1.<span class=\"Accent\">The Rare Genomes Project does not process applications to AnVIL. For more information about AnVIL or to address questions about your application, please visit <a href=\"https://anvilproject.org/\" class=\"Link\" target=\"_blank\"> https://anvilproject.org/</a>.</span>"
        },
        "Questions": {
            "Text1": "[es]If you have further questions, please contact us by email at",
            "Text2": "[es]or call us at"
        }
    },
    "LGMDPage": {
        "Title": "[es]The limb-girdle muscular dystrophy (LGMD) branch of the Rare Genomes Project is a partnership with the <a href=\"https://www.mda.org/\" target=\"_blank\" class=\"Link\">Muscular Dystrophy Association</a> and the <a href=\"https://www.jain-foundation.org/\" target=\"_blank\" class=\"Link\">Jain Foundation</a> dedicated to diagnosis and gene discovery through whole genome sequencing for individuals and families with LGMD.",
        "ImageAlt": "[es]If you or a loved one has a rare and genetically undiagnosed condition, join a patient-driven research study to discover the genes underlying your family's rare disease.",
        "Background": {
            "Title": "[es]Background",
            "Text": "[es]The limb-girdle muscular dystrophies are a group of muscle diseases characterized by weakness and wasting of the muscles in the hips, legs, shoulders, and/or other proximal muscles. There are currently over 30 known forms of LGMD, with a diverse range of clinical signs and symptoms, that collectively are estimated to affect as many as 1 in 15,000 individuals."
        },
        "Genetics": {
            "Title": "[es]Genetics and LGMD",
            "Text": "[es]Multiple studies estimate that roughly half of those undergoing genetic testing do not have a causative DNA variant in any of the known LGMD-causing genes. This project enables individuals who have had negative or incomplete results from prior genetic testing to participate in a study using whole-genome sequencing (WGS) to search for additional causes of LGMD."
        },
        "Right": {
            "Title": "[es]Is This Study Right For Me?",
            "Text": "[es]Our efforts will focus on individuals and families who:",
            "Items": [
                "Have a clinical diagnosis of LGMD*",
                "Have had prior genetic testing that was negative or did not provide a full genetic explanation*",
                "Are currently under the care of a neurologist, medical geneticist, or relevant subspecialist",
                "Live in the United States",
                "Are English-speaking"
            ],
            "Ending": {
                "Text1": "[es]*If you are unsure whether you have a clinical diagnosis of LGMD or you have not had prior genetic testing for your LGMD, you may still be eligible to participate and are encouraged to apply by",
                "Text2": "[es]clicking here"
            }
        },
        "Steps": {
            "Title": "[es]How You Can Participate",
            "One": {
                "Title": "[es]Tell us your story",
                "Text1": "[es]Click",
                "Text2": "[es]apply",
                "Text3": "[es]to tell us about the history of LGMD in your family. The information will be reviewed by our study team, and eligible families will be invited to participate. We will contact you to arrange a detailed discussion about the study and send you a consent form.",
                "Alt": "[es]Tell us your story"
            },
            "Two": {
                "Title": "[es]Submit a sample",
                "Text": "[es]Once enrolled, we’ll mail a pre-paid sample collection kit directly to you and your family. We’ll also ask you more about medical history and ask for copies of medical records, including genetic test results.",
                "Alt": "[es]Share your data"
            },
            "Three": {
                "Title": "[es]Discover",
                "Text": "[es]Through DNA sequencing, we may discover the genetic cause of the LGMD in your family and will work with you and your doctors to return important results to you. We will also share de-identified data broadly with the scientific community to empower discoveries in rare and undiagnosed disease, including LGMD.",
                "Alt": "[es]Discover"
            }
        },
        "Info": {
            "Title": "[es]Information and Resources",
            "Text": "[es]Additional information and resources for individuals with LGMD are can be found here: <a href=\"https://www.mda.org/\" target=\"_blank\" class=\"Link Accent\">Muscular Dystrophy Association</a>, <a href=\"https://www.ncbi.nlm.nih.gov/books/NBK1408/\" target=\"_blank\" class=\"Link Accent\">GeneReviews</a>, and the <a href=\"https://ghr.nlm.nih.gov/condition/limb-girdle-muscular-dystrophy#definition\" target=\"_blank\" class=\"Link Accent\"> Genetics Home Reference</a>."
        },
        "Partner": {
            "Text": "[es]We thank the Muscular Dystrophy Association for their financial support of this project.",
            "Alt": "[es]Muscular Dystrophy Association Logo"
        }
    },
    "CraniofacialPage": {
        "Title": "[es]The craniofacial branch of the Rare Genomes Project is a partnership with the <a href=\"https://www.massgeneral.org/children/services/treatmentprograms.aspx?id=1631&display=overview\" target=\"_blank\" class=\"Link\">Cleft and Craniofacial Center at Massachusetts General Hospital</a> and <a href=\"https://www.shrinershospitalsforchildren.org/boston/cleftlippalate\" target=\"_blank\" class=\"Link\">Shriners Hospitals for Children</a> dedicated to genetic diagnosis and gene discovery for congenital craniofacial conditions.",
        "Text": "[es]This project enables patients with undiagnosed, suspected single gene forms of craniofacial conditions to participate in a study using genome sequencing to search for the genetic cause of the craniofacial condition in their family.",
        "ImageAlt": "[es]If you or a loved one has a rare and genetically undiagnosed condition, join a patient-driven research study to discover the genes underlying your family's rare disease.",
        "Background": {
            "Title": "[es]Background",
            "Text": "[es]Craniofacial conditions affect the development of bones and tissues of the head and face. They can occur in isolation, with additional craniofacial conditions, or as one feature of an underlying syndrome affecting other parts of the body. For example, <a href=\"https://www.nidcr.nih.gov/health-info/cleft-lip-palate/more-info\" target=\"_blank\" class=\"Link\">facial clefts</a> can be an isolated condition, can co-occur with <a href=\"https://rarediseases.info.nih.gov/diseases/6209/craniosynostosis\" target=\"_blank\" class=\"Link\">craniosynostosis</a>, or can be part of a genetic syndrome such as <a href=\"https://rarediseases.info.nih.gov/diseases/9124/treacher-collins-syndrome\" target=\"_blank\" class=\"Link\">Treacher Collins syndrome</a>. Collectively, the many types of craniofacial conditions are estimated to affect approximately 1 in 700-1,000 newborns."
        },
        "Genetics": {
            "Title": "[es]Genetics and Craniofacial Conditions",
            "Text": "[es]Craniofacial conditions may be caused by genetic changes, environmental factors, or a combination of the two. The likelihood of a strictly genetic cause is increased if the condition is atypically severe or rare, there are delays in development or health issues affecting additional body systems, or there are multiple affected family members. Although many single gene causes have been identified, our goal is to identify additional genes that cause craniofacial conditions."
        },
        "Right": {
            "Title": "[es]Is This Study Right For Me?",
            "Text": "[es]Our initial efforts will focus on individuals and families who:",
            "ListItems": {
                "Item1": {
                    "Text": "[es]Have a craniofacial condition that is suspected to be due to a single gene. <br>Features suggesting a single gene cause include:",
                    "Subitems": {
                        "Item1": "[es]An atypically severe presentation or a rare condition",
                        "Item2": "[es]Involvement of both sides of the face or head (e.g. ears), or the middle structures (e.g. nose), depending on the condition",
                        "Item3": "[es]Additional early-onset medical conditions affecting different parts of the body or delays in development",
                        "Item4": "[es]Presence in siblings or multiple generations of family members"
                    }
                },
                "Item2": "[es]Do <span class=\"Accent\">NOT</span> have a condition with a low suspicion of a single gene cause, such as <a href=\"https://cleftline.org/family-resources/introduction-to-cleft-craniofacial-conditions/\" target=\"_blank\" class=\"Link Link--blue\"> isolated cleft lip and/or palate</a>, isolated <a href=\"http://www.childrenshospital.org/conditions-and-treatments/conditions/m/microtia\" target=\"_blank\" class=\"Link Link--blue\">microtia</a>, or <a href=\"https://rarediseases.info.nih.gov/diseases/6582/hemifacial-microsomia\" target=\"_blank\" class=\"Link Link--blue\">hemifacial microsomia</a>",
                "Item3": "[es]Are currently under the care of a medical geneticist or relevant subspecialist",
                "Item4": "[es]Live in the United States",
                "Item5": "[es]Are English-speaking"
            }
        },
        "Steps": {
            "Title": "[es]How You Can Participate",
            "One": {
                "Title": "[es]Tell us your story",
                "Text1": "[es]Click",
                "Text2": "[es]apply",
                "Text3": "[es]to tell us about the history of the craniofacial condition in your family. The information will be reviewed by our study team, and eligible families will be invited to participate. We will contact you to arrange a detailed discussion about the study and send you a consent form.",
                "Alt": "[es]Tell us your story"
            },
            "Two": {
                "Title": "[es]Submit a sample",
                "Text": "[es]Once enrolled, we’ll mail a pre-paid sample collection kit directly to you and your family. We’ll also ask you more about medical history and ask for copies of medical records, including genetic test results.",
                "Alt": "[es]Share your data"
            },
            "Three": {
                "Title": "[es]Discover",
                "Text": "[es]Through DNA sequencing, we may discover the genetic cause of the craniofacial condition in your family and will work with you and your doctors to return important results to you. We will also share de-identified data broadly with the scientific community to empower discoveries in rare and undiagnosed disease, including craniofacial conditions.",
                "Alt": "[es]Discover"
            }
        },
        "Info": {
            "Title": "[es]Information and Resources",
            "Text": "[es]Additional information and resources for individuals with isolated and syndromic craniofacial conditions can be found here: <a href=\"https://www.shrinershospitalsforchildren.org/boston/cleftlippalate\" target=\"_blank\" class=\"Link Accent\">Shriners Hospitals for Children</a>, the <a href=\"https://acpa-cpf.org\" target=\"_blank\" class=\"Link Accent\">American Cleft Palate and Craniofacial Association</a>, <a href=\"https://www.ncbi.nlm.nih.gov/books/NBK1116/\" target=\"_blank\" class=\"Link Accent\">GeneReviews</a>, and the <a href=\"https://ghr.nlm.nih.gov/\" target=\"_blank\" class=\"Link Accent\">Genetics Home Reference</a>."
        }
    },
    "StayInformedPage": {
        "Title": "[es]Stay Informed!",
        "Text": "[es]Thank you for joining the email list. We'll send you updates and keep you informed. You can unsubscribe at any time. If you have any questions about your status in the project, please email",
        "Button": "[es]Return home"
    },
    "DashboardPage": {
        "Title": "[es]My Dashboard",
        "Info": {
          "Paragraph1": "[es]Thank you for your interest in the Rare Genomes Project. This page will provide you information about the steps regarding your involvement with the study.",
          "Paragraph2": "[es]If you have questions, browse our Frequently Asked Questions page or contact the study staff at <a href=\"tel:617-714-7395\">617-714-7395</a> or <a href=\"mailto:raregenomes@broadinstitute.org\">raregenomes@broadinstitute.org</a>."
        },
        "StudyMessages": {
          "Title": "[es]Study Messages",
          "Header": {
            "Date": "[es]Date",
            "Title": "[es]Title",
            "Description": "[es]Description"
          },
          "Actions": {
            "ShowMore": "[es]Show more",
            "ShowLess": "[es]Show less"
          }
        },
        "UserActivities": {
          "Title": "[es]Study Forms",
          "Header": {
            "Form": "[es]Form",
            "Summary": "[es]Summary",
            "Status": "[es]Status",
            "Actions": "[es]Actions"
          },
          "StatusCode": {
            "CREATED": "[es]Created",
            "IN_PROGRESS": "[es]In Progress",
            "COMPLETE": "[es]Complete"
          },
          "Actions": {
            "Start": "[es]Start",
            "Continue": "[es]Continue",
            "View": "[es]View"
          },
          "NotAvailable": "[es]N/A"
        }
    },
    "ErrorPage": {
        "Title": "[es]We've encountered an error",
        "Text1": "[es]Please wait a moment and retry. If the trouble persists, please email us at",
        "Text2": "[es]or call us at"
    },
    "CountMeInPage": {
        "Title": "[es]Tell us your story",
        "SectionTitle": "[es]Thank you for your interest in joining the Rare Genomes Project!",
        "Text": "[es]To get started, please let us know if you or a loved one meets the <span class=\"Accent\">participation requirements</span> listed below by attesting that all of the statements listed next to the checkboxes below are true. You will then be asked to create a <span class=\"NotALink\"> raregenomes.org</span> account and complete a questionnaire to tell us about the rare condition in your family. The information will be reviewed by our study team, and eligible families will be invited to participate."
    },
    "SessionExpiredPage": {
        "Text1": "[es]You were away for a while, so we logged you out as a security precaution.",
        "Text2": "[es]Please log in again to return to the last page you were on.",
        "Button": "[es]Log In"
    },
    "Auth0LandingPage": {
        "Text": "[es]Please wait. You will be redirected to a destination soon..."
    },
    "EmailVerifiedCallbackPage": {
        "Header": "[es] Email verified",
        "Text": "[es] Please wait. You will be redirected to a login page soon..."
    },
    "EmailVerificationRequiredPage": {
        "Header": "[es]Email verification required",
        "Text": "[es]Please verify your email using the link that was sent to your email address."
    },
    "ThankYouPage": {
        "Title": "[es]Thank you for your interest in joining the Rare Genomes Project",
        "Paragraph1": "[es]Unfortunately, your responses to our pre-screening questionnaire do not match the <a href=\"eligibility-criteria\" class=\"Link\">current requirements for participation</a> in the study. The Rare Genomes Project can only accept applications from families who meet all of these conditions:",
        "List": [
            "[es]Understand English or Spanish",
            "[es]Live in the United States",
            "[es]Have a rare and undiagnosed genetic condition",
            "[es]Are currently under the care of a doctor helping to figure out the cause of the patient's condition"
        ],
        "Paragraph2": "[es]Over time, we may be able to expand the project. We hope you will join our mailing list. If you do, we will contact you if participation requirements change, making you eligible to apply to the study.",
        "Form": {
            "Label": "[es]Email Address *",
            "Error": "[es]Please enter a valid Email Address",
            "Submit": "[es]Join Mailing List"
        },
        "Paragraph3": "[es]If you would like your information to be deleted from our database at any time, please email us at <a href=\"mailto:raregenomes@broadinstitute.org\" class=\"Link\">raregenomes@broadinstitute.org</a>."
    },
    "Toolkit": {
        "Dialogs": {
            "JoinMailingList": {
                "Title": "[es]Stay informed!",
                "Text": "[es]Provide your email below and we'll keep you up-to-date on developments.<br>You can unsubscribe at any time.",
                "Fields": {
                    "FirstName": {
                        "Placeholder": "[es]First Name *",
                        "Error": "[es]First Name is required"
                    },
                    "LastName": {
                        "Placeholder": "[es]Last Name *",
                        "Error": "[es]Last Name is required"
                    },
                    "Email": {
                        "Placeholder": "[es]Email Address *",
                        "Error": "[es]Please enter a valid Email Address"
                    },
                    "ConfirmEmail": {
                        "Placeholder": "[es]Email Confirmation (Reenter Email) *",
                        "Error": "[es]Please enter a valid Email Address"
                    }
                },
                "CancelButton": "[es]CANCEL",
                "SubmitButton": "[es]JOIN",
                "Required": "[es]* Required field",
                "MatchEmailsError": "[es]Please ensure that both email fields are filled in and that the addresses match.",
                "LoadingError": "[es]We're sorry, but an error has occurred."
            },
            "SessionWillExpire": {
                "Title": "[es]Your session will time-out soon",
                "Text": "[es]To protect your privacy, the system is going to log you out because you have been away for a while. Click “Continue” to stay logged in. Click “Sign Out” if you are done for now.",
                "SignOut": "[es]Sign Out",
                "Continue": "[es]Continue"
            },
            "LanguagePreferences": {
                "Text": "Changing the language preference will also change the language used for e-mail communications.",
                "CheckboxText": "Don't show this again",
                "ButtonText": "OK"
            }
        }
    },
    "SDK": {
        "SubmitButton": "[es]Submit",
        "CloseButton": "[es]Close",
        "AddButton": "[es]ADD",
        "CancelButton": "[es]CANCEL",
        "NextButton": "<span class=\"fa fa-angle-right Icon--arrow material-icons mat-icon\"></span>",
        "PreviousButton": "<span class=\"fa fa-angle-left Icon--arrow material-icons mat-icon\"></span>",
        "SavingButton": "[es]Saving",
        "EditButton": "[es]View/Edit",
        "ReviewButton": "[es]View",
        "ValidateError": "[es]Please answer all the required questions above to continue",
        "CommunicationError": "[es]There was a problem saving your data. Please check the form and your answers before submitting",
        "SaveError": "[es]We're sorry but an error occurred",
        "ExportStudy": {
            "Export": "[es]EXPORT"
        },
        "ListStudies": {
            "StudyName": "[es]Study Name",
            "ParticipantCount": "[es]Participant Count"
        },
        "ListWorkspaces": {
            "WorkspaceName": "[es]Workspace Name",
            "WorkspaceNamespace": "[es]Workspace Namespace"
        },
        "Login": {
            "Login": "[es]LOG IN",
            "Logout": "[es]LOG OUT"
        },
        "SignInOut": {
            "SignIn": "Ingresar",
            "SignOut": "[es]Sign Out"
        },
        "UserActivities": {
            "ActivityName": "[es]Form",
            "Summary": "[es]Summary",
            "ActivityStatus": "[es]Status",
            "ActivityDate": "[es]Created",
            "ActivityActions": "[es]Actions"
        },
        "ManageParticipants": {
            "GovernedParticipants": "[es]Governed participants",
            "ParticipantPlaceholder": "[es]Participant",
            "ParticipantsList": "[es]Participants"
        },
        "ParticipantProfile": {
            "OpenProfile": "[es]Profile",
            "ViewAs": "[es]View As",
            "ManageParticipants": "[es]Manage participants"
        },
        "UserPreferences": {
            "UserPreferencesTitle": "[es]User preferences",
            "UserPreferencesGender": "[es]Sex",
            "UserPreferencesLocale": "[es]Preferred language"
        },
        "Dashboard": {
            "Title": "[es]My Dashboard",
            "Text": "[es]The dashboard below describes each Rare Genomes Project form and its status."
        },
        "DatePicker": {
            "Day": "[es]Choose day...",
            "Month": "[es]Choose month...",
            "Year": "[es]Choose year...",
            "January": "[es]January",
            "February": "[es]February",
            "March": "[es]March",
            "April": "[es]April",
            "May": "[es]May",
            "June": "[es]June",
            "July": "[es]July",
            "August": "[es]August",
            "September": "[es]September",
            "October": "[es]October",
            "November": "[es]November",
            "December": "[es]December"
        },
        "DateLabel": {
            "YYYY": "AAAA",
            "MM": "MM",
            "DD": "DD"
        },
        "UserMenu": {
            "DashboardButton": "[es]Dashboard",
            "SignOutButton": "[es]Sign Out"
        },
        "DetailsPlaceholder": {
            "PluralForm": "[es]characters remaining",
            "SingularForm": "[es]character remaining"
        },
        "Title": {
            "Default": "[es]Rare Genomes Project",
            "Alert": "[es]Your session will time-out soon"
        },
        "EmailEntry": {
            "InvalidEmail": "[es]Please enter a valid email"
        },
        "Institutions": {
            "Fields": {
                "Name": "[es]Physician Name",
                "Institution": "[es]Institution",
                "InstitutionAny": "[es]Institution (if any)",
                "City": "[es]City",
                "State": "[es]State"
            },
            "Form" : {
                "OtherPhysician": "Otro doctor",
                "OtherInstitution": "Otra institución"
            },
            "PhysicianValidation": "[es]Please fill out all required fields"
        },
        "Validators": {
            "DateNavyValidationRule": "[es]Entered date is invalid"
        },
        "ConfirmDeletion": "[es]Are you sure you want to delete \nthis information?",
        "DeleteButton": "[es]Delete",
        "CancelBtn": "[es]Cancel"
    }
}
